Nu Skin (NUS) EVP and General Counsel receives new performance-based share awards

Rhea-AI Filing Summary

Nu Skin Enterprises EVP and General Counsel Chayce David Clark reported stock awards tied to performance goals being met. On February 10, 2026, he acquired 15,667 Class A shares and another 75,466 Class A shares at $0.00 per share as performance-based restricted stock units became eligible for vesting. Following these awards, he directly holds 315,224 Class A shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Clark Chayce David

Role EVP and General Counsel

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	15,667	$0.00	--
Grant/Award	Class A Common Stock	75,466	$0.00	--

Holdings After Transaction: Class A Common Stock — 239,758 shares (Direct)

Footnotes (1)

1. On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Clark Chayce David

(Last) (First) (Middle)

C/O NU SKIN ENTERPRISES, INC.

75 W CENTER STREET

(Street)

PROVO UT 84601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/10/2026		A		15,667(1)	A	$0.00	239,758	D
Class A Common Stock	02/10/2026		A		75,466(2)	A	$0.00	315,224	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

2. On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

	/s/ Gregory Belliston as Attorney-in-Fact for Chayce Clark	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NUS executive Chayce David Clark report?

Chayce David Clark reported acquiring Class A common stock through awards. On February 10, 2026, he received 15,667 shares and 75,466 shares at $0.00 per share as performance-based restricted stock units became eligible for vesting, increasing his direct holdings to 315,224 shares.

What role does Chayce David Clark hold at Nu Skin Enterprises (NUS)?

Chayce David Clark serves as EVP and General Counsel at Nu Skin Enterprises. His Form 4 filing reflects equity compensation in the form of performance-based restricted stock units that became eligible for vesting, resulting in additional Class A common shares being acquired directly in his name.

How many Nu Skin (NUS) shares does Chayce David Clark own after this Form 4?

After the reported transactions, Clark beneficially owns 315,224 Class A common shares directly. This figure reflects the addition of 15,667 and 75,466 shares that became eligible for vesting when Nu Skin met specific performance criteria on February 10, 2026, under prior RSU grants.

What triggered the Nu Skin (NUS) stock awards reported by Chayce David Clark?

The awards were triggered when Nu Skin satisfied performance criteria attached to prior restricted stock unit grants. RSUs granted in February 2024 and February 2025 became eligible for vesting on February 10, 2026, resulting in the issuance of the reported Class A common shares at no cash cost.

Were the NUS insider transactions reported by Clark purchases or awards?

The transactions were awards, not open-market purchases. They are coded as “A” for grant, award, or other acquisition, with a price of $0.00 per share, reflecting performance-based restricted stock units becoming eligible to vest rather than shares bought for cash.

What are the performance-based RSUs mentioned in the NUS Form 4 filing?

The performance-based RSUs are stock units granted in 2024 and 2025 that depended on Nu Skin meeting specific performance criteria. Once those criteria were achieved on February 10, 2026, the corresponding amounts of Class A common stock became eligible for vesting and were reported as acquired.